Literature DB >> 17020882

Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells.

Xiangyang Jiao1, Paul C Billings, Michael P O'Connell, Frederick S Kaplan, Eileen M Shore, David L Glaser.   

Abstract

Cell surface heparan sulfate proteoglycans (HSPGs) have been implicated in bone morphogenetic protein (BMP)-mediated morphogenesis by regulating BMP activity and gradient formation. However, the direct role of HSPGs in BMP signaling is poorly understood. Here we show that HSPGs directly regulate BMP2-mediated transdifferentiation of C2C12 myoblasts into osteoblasts. HSPGs sequester BMP2 at the cell surface and mediate BMP2 internalization. Depletion of cell surface HSPGs by heparinase III treatment or decreased glycosaminoglycan chain sulfation with sodium chlorate enhances BMP2 morpho-genetic bioactivity. The addition of exogenous heparin, a widely used anticoagulant, reduced BMP2 signaling. Our results suggest that cell surface HSPGs mediate BMP2 internalization and modulate BMP2 osteogenic activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020882     DOI: 10.1074/jbc.M513414200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Proteoglycans and osteolysis.

Authors:  Marc Baud'Huin; Céline Charrier; Gwenola Bougras; Régis Brion; Frédéric Lezot; Marc Padrines; Dominique Heymann
Journal:  Methods Mol Biol       Date:  2012

2.  Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2.

Authors:  Gajadhar Bhakta; Bina Rai; Zophia X H Lim; James H Hui; Gary S Stein; Andre J van Wijnen; Victor Nurcombe; Glenn D Prestwich; Simon M Cool
Journal:  Biomaterials       Date:  2012-06-09       Impact factor: 12.479

3.  Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.

Authors:  Shaoliang Li; Chisei Shimono; Naoko Norioka; Itsuko Nakano; Tetsuo Okubo; Yoshiko Yagi; Maria Hayashi; Yuya Sato; Hitomi Fujisaki; Shunji Hattori; Nobuo Sugiura; Koji Kimata; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

4.  Customized Ca-P/PHBV nanocomposite scaffolds for bone tissue engineering: design, fabrication, surface modification and sustained release of growth factor.

Authors:  Bin Duan; Min Wang
Journal:  J R Soc Interface       Date:  2010-05-26       Impact factor: 4.118

5.  Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.

Authors:  Christina Mundy; Evan Yang; Hajime Takano; Paul C Billings; Maurizio Pacifici
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

Review 6.  Extracellular matrix and its receptors in Drosophila neural development.

Authors:  Kendal Broadie; Stefan Baumgartner; Andreas Prokop
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

7.  Gel scaffolds of BMP-2-binding peptide amphiphile nanofibers for spinal arthrodesis.

Authors:  Sungsoo S Lee; Erin L Hsu; Marco Mendoza; Jason Ghodasra; Michael S Nickoli; Amruta Ashtekar; Mahesh Polavarapu; Jacob Babu; Rehan M Riaz; Joseph D Nicolas; David Nelson; Sohaib Z Hashmi; Start R Kaltz; Jeffrey S Earhart; Bradley R Merk; Jeff S McKee; Shawn F Bairstow; Ramille N Shah; Wellington K Hsu; Samuel I Stupp
Journal:  Adv Healthc Mater       Date:  2014-04-22       Impact factor: 9.933

8.  Harnessing endogenous growth factor activity modulates stem cell behavior.

Authors:  Gregory A Hudalla; Nicholas A Kouris; Justin T Koepsel; Brenda M Ogle; William L Murphy
Journal:  Integr Biol (Camb)       Date:  2011-07-01       Impact factor: 2.192

9.  Morphogen gradients in development: from form to function.

Authors:  Jan L Christian
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2011-11-17       Impact factor: 5.814

10.  Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization.

Authors:  Wan-Jong Kuo; Michelle A Digman; Arthur D Lander
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.